Trial Profile
Immunosuppression in Renal Transplantation in The Elderly: Time to Rethink. - nEverOld Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate sodium (Primary) ; Tacrolimus (Primary) ; Prednisone
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms nEverOld
- 05 Jun 2019 Status changed from recruiting to completed according to results presented at the 2019 American Transplant Congress.
- 18 Sep 2018 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 01 Jun 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.